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published March 18, 2015; doi:10.1152/ajpcell.00395.2014.—Cal-
cium signaling is essential to support erythroid proliferation and
differentiation. Precise control of the intracellular Ca2 levels in
erythroid precursor cells (EPCs) is afforded by coordinated expression
and function of several cation channels, including the recently iden-
tified N-methyl-D-aspartate receptor (NMDAR). Here, we character-
ized the changes in Ca2 uptake and electric currents mediated by the
NMDARs occurring during EPC differentiation using flow cytometry
and patch clamp. During erythropoietic maturation, subunit composi-
tion and properties of the receptor changed; in proerythroblasts and
basophilic erythroblasts, fast deactivating currents with high ampli-
tudes were mediated by the GluN2A subunit-dominated receptors,
while at the polychromatic and orthochromatic erythroblast stages, the
GluN2C subunit was getting more abundant, overriding the expres-
sion of GluN2A. At these stages, the currents mediated by the
NMDARs carried the features characteristic of the GluN2C-contain-
ing receptors, such as prolonged decay time and lower conductance.
Kinetics of this switch in NMDAR properties and abundance varied
markedly from donor to donor. Despite this variability, NMDARs
were essential for survival of EPCs in any subject tested. Our findings
indicate that NMDARs have a dual role during erythropoiesis, sup-
porting survival of polychromatic erythroblasts and contributing to the
Ca2 homeostasis from the orthochromatic erythroblast stage to
circulating red blood cells.
calcium; differentiation; erythropoiesis; NMDA receptor
EVERY HOUR, APPROXIMATELY 1010 new erythrocytes are released
into the circulation in an adult human after having undergone
a tremendous variety of critical transformations during eryth-
ropoiesis. These sequential transformations occur within sev-
eral days and are controlled by numerous intracellular and
extracellular regulatory factors. Erythropoietin (Epo) and Ca2
ions are two of the essential players in signaling cascades that
support cell survival, proliferation, and differentiation of EPCs
through stages from burst-forming units-erythroid (BFUe) to
red blood cells (RBCs) (9, 30, 53, 61). The key role of
stage-specific alterations in intracellular Ca2 levels and the
underlying changes in activity of Ca2 transport pathways in
the EPCs have been reported previously (21, 42, 53). Omission
of extracellular Ca2 completely inhibits erythopoietic matu-
ration (44). Given its importance, the molecular identity of ion
channels mediating Ca2 uptake by EPCs during the early
stages of maturation has been a subject of intensive investiga-
tion (11, 15, 42). In human and mouse EPCs, Ca2 influx that
is mediated by transient receptor potential channels (TRPCs)
contributes to the Epo-Epo receptor (EpoR)-mediated signaling
(10, 11, 15, 42, 58). Indeed, Epo regulates, in a concentration-
dependent manner, Ca2 influx into already hemoglobinized
BFUe-derived EPCs, but not in EPCs at earlier stages of
differentiation (24). However, Cheung et al. (8) have reported
that Ca2 influx induced by Epo was insufficient to activate
Ca2-sensitive K channels (Gardos channel). This strongly
indicates the presence of multiple Ca2 uptake pathways in
EPCs during differentiation (52). We have recently reported
the presence of N-methyl-D-aspartate receptors (NMDARs) in
human progenitor cells and have shown that these nonselec-
tive, ligand-gated cation channels mediate Ca2 uptake in
EPCs (18, 35).
NMDARs are best characterized in neurons, but are not
limited to the central and peripheral nervous system alone.
Indeed, these receptors have been reported in a variety of cells
and tissues, including osteoclasts, megakaryocytes, leucocytes,
and RBCs (28, 35, 37, 39, 41). NMDARs are formed of
glycine-binding subunits GluN1 and GluN3A/3B, and gluta-
mate-binding subunits GluN2A/2B/2C/2D (12, 46, 59). For
full activation, the heteromeric ion channel requires glutamate
and the cotransmitters glycine (in the brain) or D-serine (in the
spinal cord) (12). Depending on the subunit composition,
cation selectivity, deactivation time, conductance, sensitivity to
Mg2 inhibition, and pharmacology of the NMDARs vary
greatly (6, 46, 50). NMDARs containing GluN2C/2D have a
lower conductance and a prolonged decay time (45, 47).
Combination of these subunits with GluN3A/B results in a
further decrease in the current amplitude, distinct channel
properties, and altered pharmacology (6, 7, 34). In contrast,
NMDAR containing the GluN2A subunit has a fast decay time
and higher conductance (55). Recently, we have shown that
expression of the GRIN2C (GluN2C) and GRIN3B (GluN3B)
mRNA levels increased progressively from proerythroblast to
orthochromatic erythroblast stage, whereas GRIN2A gene, cod-
ing for the GluN2A subunit, exhibited a high interindividual
variability during maturation (35). This study was designed to
characterize the function of the NMDARs expressed in EPCs at
various stages of differentiation. Using an ex vivo erythropoi-
etic maturation system, we monitored Ca2 uptake and ionic
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currents induced by NMDAR agonists in human basophilic,
polychromatic, and orthochromatic erythroblasts derived from
isolated mononuclear cells to determine the stage-dependent
alterations in NMDAR channel properties which mirrored the
switch in subunit expression pattern observed at the transcrip-
tional level (18, 35). Our new findings demonstrate the impor-
tance of the NMDAR in protecting the EPCs against apoptosis.
MATERIALS AND METHODS
Human blood samples and isolation of CD34 and erythropoietic
precursor cells. Blood samples were obtained at the University
Children’s Hospital Zurich, Switzerland, or mononuclear cells were
bought as a product from the Welsh blood bank in Cardiff, UK. All
blood donors (n  16 donors, both sexes, ages between 18 and 49 yr,
Caucasian) provided written informed consent in accordance with the
Declaration of Helsinki. Mononuclear cells were isolated from hepa-
rinized venous blood on a Ficoll-Paque PLUS gradient according to
the protocol provided by GE-Healthcare (Dietikon, Switzerland).
Ex vivo hematopoiesis. Freshly isolated mononuclear cells were
cultured in a two-phase liquid system as described elsewhere (35, 40).
During the first phase, cells were maintained in StemSpan Serum-Free
Medium for expansion of Hematopoietic Cells (SFEM) containing
0.51 mM L-glutamic acid and 0.4 mM glycine supplemented with
StemSpan CC100 Cytokine mixture (StemCell Technologies,
Grenoble, France) and 2% of penicillin-streptomycin (Sigma-Al-
drich). After 4 days in culture, nonadherent cells were reseeded in
StemSpan SFEM containing 20 ng/ml stem cell factor, 5 ng/ml
interleukin-3, 1 unit Epo (all provided by ProSpec-Tany Techno-
Gene, Ness-Ziona, Israel) and 2% of penicillin-streptomycin (Sigma-
Aldrich).
Morphological characterization. Cell morphology was assessed
microscopically after cytocentrifugation (Cytospin 4 Cytocentrifuge,
Thermo Fisher Scientific, Reinach, Switzerland) and May-Grünwald-
Giemsa staining as described elsewhere (40). Differentiation state of
the erythropoietic precursor cells (EPCs) was evaluated with the Axio
Imager 2 Research Microscope (Carl Zeiss, Feldbach, Switzerland).
Standard morphological appearance of basophilic, polychromatic,
orthochromatic erythroblasts and reticulocytes is represented in mul-
tiple sources (e.g., Ref. 1).
Flow cytometry. To measure the changes in intracellular Ca2
levels, cells were loaded with 3 M FLUO-4 AM for 30 min,
followed by a further 30 min of treatment with the following anti-
human monoclonal antibodies: CD34, (eFluor 450 conjugated, clone
4H11, Ref. 48-0349-42), CD71, (APC conjugated, clone OKT9, Ref.
17-0719) both from eBiosciences (San Diego, CA), and CD117 (PC7
conjugated, clone 104D2D1, PN IM3698), CD235a (APC-Alexa
Fluor 750 conjugated, clone KC16, PN A89314), and CD45 (Krome
Orangeconjugated, clone J.33, PN A96416) all from Beckman
Coulter. Loading with both the fluorescent probe and the antibodies
was performed in StemSpan SFEM medium (containing 0.51 mM
glutamate and 0.4 mM glycine). Preincubation with the receptor
antagonist MK-801 (80 M) for 30 min also occurred in the cell
culture medium in a humidified atmosphere with 5% CO2 at 37°C.
Incubation with FLUO-4 AM, antibodies against the surface markers,
and antagonist was performed in cell culture medium to mimic the
“physiological conditions” in which basal level of NMDAR activation
was maintained. Furthermore, MK-801 can only bind to activated
NMDAR. Cell culture medium was replaced by the FACS solution in
which cells were washed twice and resuspended before the assessment
of fluorescence intensity. FACS solution contained (in mM) 135
NaCl, 5 KCl, 5 HEPES, 10 D-glucose, 2 CaCl2 and was adjusted to pH
7.35 with NaOH. Agonist-induced Ca2 uptake was recorded as
response to the administration of 150 M NMDA and 50 M glycine
(NMDA/GLY) to the cell-containing FACS medium. In a separate set
of experiments, apoptotic markers were detected in EPCs pretreated
with 500 M MK-801 or memantine for 12 h in glutamic acid- and
glycine-containing StemSpan SFEM. Those markers included
caspases 3, 8, 9 and phosphatidylserine. Unstained (blank, red histo-
grams) and unstimulated (control, green histograms) cells were used
as controls. All experiments have been performed in triplicate, and
15,000 to 35,000 cells had been analyzed at each occasion. Galios
Flow Cytometer software was used for data acquisition and Kaluza
1.2 software (Beckman Coulter) was applied for analysis.
Electrophysiology. Electrophysiological experiments were per-
formed using EPCs obtained from eight donors between day 7 and 20
of erythropoietic maturation. Nonadherent EPCs were plated down on
coverglasses coated with poly-L-lysine solution (0.01% vol/wt in
H2O). Cells were voltage clamped during continuous perfusion at
room temperature.
Protocols used elsewhere (14) to record NMDA-induced whole cell
currents were adapted for detection of NMDAR activity in EPCs with
some modification. The internal solution contained (in mM) 115
N-methyl-D-glucamine (NMDG)-HCl, 40 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), 10 ethylene glycol-bis(-
aminoethyl ether)-N,N,N=,N=-tetraacetic acid (EGTA), 2 Na2ATP, and
0.2 Na3GTP and pH was adjusted to 7.2–7.25 by HCl titration and
osmolality to 280–285 mosmol/kgH2O. The external solution con-
tained (in mM) 127 NaCl, 20 CsCl, 12 D-glucose, 10 HEPES, 5 BaCl2,
2 CaCl2, with pH adjusted to 7.35 and osmolality to 300–305
mosmol/kgH2O. Cs and Ba2 were used to reduce K conductance.
High concentration of EGTA was applied to bind the residual free
Ca2 after depolarization. To record passive membrane currents,
standard intracellular solution containing (in mM) 117 KCl, 11
HEPES, 11 EGTA, 10 NaCl, 2 MgCl2, 2 Na2ATP, 1 CaCl2 adjusted
to pH 7.2 with KOH was used. The standard extracellular solution
consisted of (in mM) 135 NaCl, 5 KCl, 5 HEPES, 10 D-glucose, 1.5
CaCl2, adjusted to pH 7.35 with NaOH. Junction potential was
Fig. 1. Stage-dependent N-methyl-D-aspartate receptor (NMDAR) subunit expression during ex vivo erythropoietic maturation. A: differentiation stages of
erythroid precursor cells (EPCs) in culture derived from peripheral blood-borne CD34 cells were analyzed morphologically and by the presence of the
differentiation markers (CD34, CD117, CD71, and CD235a) assessed by flow cytometry (56) and matched with the -globin, GRIN2C, and GRIN3B transcript
abundance during ex vivo erythropoietic maturation (36). EpoR, erythropoietin (Epo)-Epo receptor; BFUe, burst-forming units-erythroid; CFUe, colony-forming
units- erythroid. B: green histograms (control, unstimulated) showing CD34, CD117, CD71, and CD235a abundance in the EPCs at days 8 (basophilic
erythroblasts) and 16 (orthochromatic erythroblasts) in culture. Horizontal bars indicate the A gate selection. Shown in red are the histograms for the unstained
cells (blank). CD45 was used to assess the fraction of white blood cells in erythroid cultures (quantification of the data and statistics are presented in Table 1).
Table 1. Characterization of erythropoietic maturation with specific surface marker
Day of Maturation CD34 Cells (Gate A) CD117 Cells (Gate A) CD71 Cells (Gate A) CD235a Cells (Gate A) CD45 Cells (Gate A)
Day 8 2.30 1.83% 62.72 14.89% 80.04 9.53% 50.06  11.21% 0.08 0.34%
Day 16 0.00 0.01% 0.77 1.45% 83.12 10.12% 69.69  19.63% 0.00 0.01%
The percentage of cells in gate A (see Fig. 1B) presented as mean  SD (n  9 different donors).
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adjusted after seal formation. For single recordings, high-resistance
seals (G seals) were formed, and cells were stable for 2–10 min.
External and pipette solution (in mM: 117 KCl, 11 HEPES, 10 NaCl,
10 D-glucose, and 1.5 CaCl2) was used to record single-channel
activity. The pH was adjusted with NaOH to 7.35. Currents were
normalized to the cell capacitance (pA/pF). Patch pipettes were pulled
from borosilicate glass (GC100F-15, Harvard Apparatus, Holliston,
MA) and fire polished. When filled with this pipette solution, they had
tip resistances of between 9 and 12 M in the bath solution. Axopatch
200B amplifier, Digidata 1440A, and pClamp 10.3 were used to
acquire and filter (5 kHz) data (Axon CNS, Molecular Devices,
Downingtown, PA). Leak current in whole cell recordings was sub-
tracted manually. The electrophysiological properties of the EPC
membranes were assessed using a voltage-step protocol, which held
the voltage at 	70 mV and stepped for 200 ms from 	120 mV to
60 mV, in 10-mV increments. Agonist-evoked currents were re-
corded while holding the membrane at 	60 mV. A voltage-step
protocol described elsewhere (48) with a sequence of a hyperpolar-
izing step (	100 mV) and two depolarizing steps (30 mV and 80
mV) was applied to liberate Mg2 from the pore receptor prior to
testing of the effects of pore-targeting NMDA antagonists MK-801
and memantine (48). NMDAR modulators were added at the holding
potential of 	60 mV. The recordings were performed at the depolar-
izing step (100 mV). To ensure fast drug application, a Rapid
Solution Changer System was used, which allowed solution changes
within 20 ms. All chemicals were purchased from Sigma-Aldrich.
Statistical analysis. Data are presented as means  SD. Statistical
analysis was performed using one-way ANOVA with Bonferroni’s
multiple comparison test, Kruskal-Wallis with Dunn’s post test, or
Student’s paired t-test, as appropriate. For all tests, significance was
set at P 
 0.05.
RESULTS
Ex vivo erythropoietic maturation. Characteristic changes in
differentiating EPC cultures were monitored by morphological
examination (Fig. 1A). In addition, hemoglobin accumulation
and the expression of stage-specific markers such as CD34,
CD117, CD71, and CD235a were assessed. These differentia-
tion steps were associated with the alteration in the levels of
transcripts for the GRIN genes (Fig. 1B) and corresponding
protein abundance of NMDAR subunits (Fig. 1A) (18, 35).
EPCs are referred to as the dominant (80%) cell type at the
specific day as the cell population has never been completely
homogeneous. On day 8 of erythropoietic maturation, 2.3%
still expressed CD34, the rest of the EPCs had differentiated to
proerythroblasts. White blood cells (CD45) could not be
traced. In all experiments, the proportion of CD45 cells was

0.01%. After 8 days in culture, the majority of EPCs had
differentiated into basophilic erythroblasts with characteristic
morphology (large cells with large nuclei with clumped chro-
matin, no nucleoli seen) and the onset of CD117 expression.
On day 12, the majority of the EPCs were smaller in size with
further progressing chromatin condensation in the nucleus and
low hemoglobinization (Fig. 1A). The EPCs expressed CD71
and CD235a and were CD117 negative. These characteristics
indicated that at day 12 the polychromatic erythroblast stage
was dominant. On day 16, most of the EPCs appeared to be
smaller, with highly condensed nuclear and strongly hemoglo-
binized and expressing CD71 and CD235a and defined as
orthochromatic erythroblasts (Fig. 1 and Table 1). Enucleation
and reticulocyte formation occurred intensively after day 17 in
culture, with 90% of all EPCs losing nucleus by day 20 as
shown in Fig. 1A.
NMDA-induced whole cell currents and Ca2 influx in EPCs
during differentiation stages. Activity of NMDARs in baso-
philic, polychromatic, and orthochromatic erythroblasts was
determined by monitoring whole cell currents and Ca2 uptake
Fig. 2. Stage-dependent Ca2 influx into the EPCs upon stimulation with NMDA and glycine (GLY) in the absence or absence of MK-801. The size of cell
population responding to the stimulation with NMDA/GLY (150 M/50 M) with Ca2 uptake was tested in the EPCs derived from nine different donors at
days 8, 12, and 16 in culture. Changes in intracellular Ca2 were evaluated with Ca2 indicator FLUO-4. A: representative histograms showing fluorescence
intensity in unstimulated cells (control, shown in green), cells stimulated with NMDA (150 M) and glycine (50 M) (NMDA/GLY, in blue), and stimulated
cells in the presence (MK-801  NMDA/GLY, in yellow) of antagonist MK-801 (60 M). Blank (unstained) readouts from the cells free from fluorophore are
shown in red. At day 8 of maturation one population of cells with high FLUO-4 intensity (gate A) and one with low FLUO-4 intensity (gate B) were present.
At later stages only one population was present (gate A). Quantification of the data is presented in Table 2. B: dot plots illustrating relative change of intracellular
Ca2 levels in CD71 cells (gate A- and gate A). Presented are the representative readouts from the EPCs at day 12 in culture in which Ca2-sensitive
fluorescence of FLUO-4 was recorded in unstimulated cells (control), in stimulated (NMDA/GLY) cells, and in stimulated cells in the presence of antagonist
(MK-801  NMDA/GLY). Quantification of the data is presented in Table 3. C: Ca2 uptake by the EPCs upon the stimulation with NMDA/GLY on average
decreased during maturation from day 8 to day 16 in culture (##P 
 0.01 compared with values for day 8). Inhibition of NMDAR by MK-801 resulted in
significant reduction of intracellular Ca2 at all stages of maturation (*P 
 0.05 and **P 
 0.01 compared with the antagonist-free cells). All experiments were
performed in triplicate for each of nine donors used in these experiments. The amount of cells analyzed for each single recording ranged from 15,000 to 35,000.
Data were normalized to the values obtained for unstimulated EPCs (dashed line). Box plots show the median and 95% confidence interval.
Table 2. Ca2 influx upon stimulation with NMDA/GLY in the absence or presence of MK-801 at various
differentiation stages
Treatment
Day of Maturation (Gate)
Day 8 (Gate A) Day 8 (Gate B) Day 12 (Gate A) Day 16 (Gate A)
FLUO-4 Intensity
(Gated Cells) GMF
FLUO-4 Intensity
(Gated Cells) GMF
FLUO-4 Intensity
(Gated Cells) GMF
FLUO-4 Intensity
(Gated Cells) GMF
Control 18.17 8.19% 11.46 14.66 6.21% 9.25 30.97 7.27% 11.70 59.95 9.73% 4.08
NMDA/GLY 56.06 6.14% 30.83 18.01 2.69% 9.88 60.79 5.88% 21.07 64.71 6.17% 4.46
MK-801  NMDA/GLY 37.89 7.08% 17.82 16.68 4.82% 9.23 38.94 8.53% 13.39 37.37 7.41% 2.36
Measurements were performed in repetitive erythroid precursor cell EPCs) cultures (n  3) from the same donor. Gating conditions are exemplified in Fig
2A and are presented in the table as the mean percentage of cells in the gate SD and geometric mean fluorescence (GMF). NMDA, N-methyl-D-aspartate; GLY,
glycine.
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in a group of healthy human donors that were involved in
previous molecular characterization of the receptor (18, 35).
Since NMDARs, but not the other ionotropic glutamate recep-
tors, are highly sensitive to N-methyl-D-aspartate, we mainly
used NMDA for the receptor stimulation. Nonetheless, similar
currents were induced by 250 M glutamate and 50 M
glycine (data not shown).
Ca2 uptake via the NMDAR was recorded in the cells,
which were transferred from the glutamate and glycine-con-
taining culture medium to agonist-free culture medium. There-
after the cells were stimulated with the agonists (NMDA/
GLY). The number of EPCs responding to the stimulation with
induction of Ca2 uptake (NMDA/GLY) (exemplified in Fig.
2A and Table 2) decreased with differentiation of basophilic
erythroblasts to polychromatic and orthochromatic erythro-
blasts (24.9  17.9%, 14.4  9.6%, and 7.8  8.5% of
“responding cells” in the population, respectively) (Fig. 2C).
All cells responded to stimulation with the NMDAR agonists
with an increase in the intracellular Ca2-expressed CD71
(gate A in Fig. 2B and Table 3). The amplitude of Ca2
uptake in erythroid precursor cells caused by the stimulation
with NMDA/GLY reduced with differentiation from basophilic
(day 8) to orthochromatic (day 16) erythroblasts (Fig. 2C). In
orthochromatic erythroblasts (day 16), MK-801 treatment re-
sulted in a modest, but significant decrease in intracellular
Ca2 levels (2.5  9.1%) compared with the unstimulated
EPCs (dotted line in Fig. 2C). Whole cell voltage-clamp
recordings were used to verify the data obtained by flow
cytometry. At a holding potential of	60 mV, coadministration
of NMDA and GLY for 500 ms resulted in induction of
currents with characteristics depending on the differentiation
stage of the EPCs, as illustrated in Fig. 3A. Stimulation of the
EPCs in whole cell and single-channel configuration with
-amino butyric acid (GABA) used as a negative control was
without an effect (data not shown).
In basophilic erythroblasts (Fig. 3A, day 8), stimulation with
agonists immediately induced currents with a density of
77.41  31.81 pA/pF (Fig. 3B) and a deactivation time of
332.0  149.4 ms (Fig. 3C). Desensitization of the channels
was observed upon repetitive stimulation with the agonists
(Fig. 3D). Maturation to polychromatic erythroblasts (Fig. 3A,
day 12) was associated with a decrease in current density to
40.96  25.13 pA/pF (Fig. 3B) and prolongation of deactiva-
tion to 591.3  206.2 ms (Fig. 3C). This tendency persisted
with differentiation to orthochromatic erythroblasts (Fig. 3A,
day 16) in which current density declined further to 16.01 
7.81 pA/pF (Fig. 3B) while deactivation time increased to
1,139.1  382.9 ms (Fig. 3C). The number of cells, which
were sensitive to agonist stimulation, declined during matura-
tion, from 24.9  13.3% in basophilic erythroblasts to 18.6 
9.3% of polychromatic erythroblasts, making up only 8.4 
8.6% in orthochromatic erythroblasts. The number of cells
responding to the stimulation of NMDARs at various dif-
ferentiation stages was identical no matter what technique
(electrophysiology or flow cytometry) was used for detec-
tion of the NMDAR activation (Fig. 3E).
Sensitivity of agonist-induced currents to MK-801 and
memantine. We have explored the sensitivity of currents in-
duced by the receptor agonists to the potent and selective
NMDAR channel blockers MK-801 (60 M) and memantine
(80 M). As shown in Fig. 3F, these noncompetitive antago-
nists reduced the agonist-sensitive current density significantly.
The application of MK-801 decreased the current density
mediated by the NMDARs from 62.77  10.42 pA/pF to
42.12  8.51 pA/pF and memantine suppressed the mean
current density to 46.82 10.29 pA/pF. Long-term application
of NMDA and glycine and repetitive performance of the
voltage-step protocol induced deactivation (Fig. 3, D and G).
Further inhibition of current density could be mediated by
MK-801 supplementation (Fig. 3G).
Activation of single channels after application of NMDA and
glycine. The effects of NMDAR activation and the concomi-
tant Ca2 uptake on the activity of ion channels is consistent
with the properties of Ca2-activated K channels and were
determined in the cell-attached configuration. The single Ca2-
sensitive K channel currents (Fig. 4A) had a current-voltage
(I–V) relationship resembling the characteristics of Gardos
channels (13). The conductance of 23 pS of the channels was
determined from the slope of the regression line. This value
was similar to the conductance of 18–22 pS reported for the
Gardos channels in mature red blood cells (16, 17, 27). Stim-
ulation of reticulocytes with the NMDAR agonists induced a
6.7-fold increase in the product of open state probability
(Popen) and number (N) of open channels (NPopen) (0.64 0.19
vs. 0.09  0.16 in nonstimulated cells) in 8.6  7.4% of cells
between day 17 and day 20 in culture (Fig. 4, B and C). The
single-channel activity decreased after 30 s of stimulation
with agonists. Removal of the agonists resulted in recovery of
the basal channel activity within 2 min. The spontaneous
activity of these channels has been previously described by
Dyrda et al. (13), and attributed to pressure activation. Further
characterization of the Ca2-sensitive K current was outside
the scope of the study.
Interindividual variability of NMDAR activity correlates
with the changes in GluN subunit expression levels during
maturation. We have monitored interindividual variability in
the relative mRNA expression of GRIN2A at day 8 and the
relative change of intracellular Ca2 concentration after
NMDAR activation that was recorded as a shift in geometric
mean fluorescence (GMF). GRIN2A expression of individ-
ual donors correlated with the amplitude of changes in
Table 3. Reduction of NMDAR-mediated Ca2 influx after pretreatment with MK-801 in CD71 cells
Treatment Gate A		 (Gated Cells) Gate A	 (Gated Cells) Gate A	 (Gated Cells) Gate A (Gated Cells)
Control 24.53 4.55% 1.01  0.85% 67.82  7.41% 6.64 5.00%
NMDA/GLY 25.77 3.89% 2.42  1.19% 38.65  4.02%* 33.16 5.03%*
MK-801  NMDA/GLY 29.02 3.81% 1.63  2.25% 60.72  4.49% 8.63 4.83%
The distribution of cells between the quadrants (see Fig. 2A) presented as mean % SD. *P
 0.01, compared with the unstimulated control (Student’s paired
t-test).
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the intracellular Ca2 levels after NMDAR stimulation
(Fig. 5A).
In basophilic erythroblasts, low levels of the GRIN2C and
GRIN3B transcripts were associated with a prominent increase
in the intracellular Ca2 upon NMDAR activation (Fig. 6A).
Inverse correlation was observed between the upregulation of
the GRIN2C and GRIN3B genes and the amplitude of Ca2
uptake in the EPCs stimulated with the NMDAR agonists
during the transformation into polychromatic and orthochro-
matic erythroblasts (Fig. 6B).
Further correlations were detected between the type of
NMDA-induced current and the subunit expression pattern.
Deactivation time correlated inversely with the relative
GRIN2A expression levels of individual donors (Fig. 5C).
A switch in NMDAR properties from channels with high
amplitude and fast decay currents, characteristic of the baso-
philic erythroblasts, to currents of smaller amplitude and lon-
ger deactivation time from polychromatic erythroblast stage
onwards, mirrored a switch from the GluN2A to GluN2C/3B in
all nine donors (Fig. 6, B and C).
Alteration in electrophysiological properties during enucle-
ation of erythropoietic cells. Besides the above-mentioned
stage-dependent switch in NMDAR properties and the basal
intracellular Ca2 levels, alterations in basal electrophysiolog-
ical properties of the EPC membranes exhibited during enu-
cleation.
Current-voltage relationship within the 	120 to 60 mV
potential range showed no substantial changes until day 15 of
differentiation. A representative I–V curve (current type A)
recorded from basophilic and polychromatic erythroblasts
showed characteristic lack of voltage dependence within the
range of potentials from 	90 mV to 30 mV resembling the
I–V relationship reported for chloride channels reported to be
present in RBCs (26, 57) (Fig. 7, A and D). During enucleation
(between day 16 and 18), a switch from voltage-independent to
two types of voltage-dependent behavior occurred in 82.8 
1.01% of cells (Fig. 7, B–E). The majority of cells (70.8 
3.01%) exhibited a steep increase in conductance during de-
polarization from 	20 mV to 50 mV (current type B), a
feature characteristic of certain potassium channel types (25,
26, 57) (Fig. 7, B and D). In 12.0  2.01% of EPCs a
bell-shaped I–V relation (type C current) with maximal current
density monitored at 30 mV was observed (Fig. 7, C and D).
At day 18 of differentiation, in 17.2  1.0% of cells the I–V
relationship (type A current) remained essentially voltage in-
sensitive (Fig. 5E). Further in-depth studies are required for
detailed characterization and molecular identification of all ion
channels contributing to these basal electrophysiological prop-
erties.
Treatment of the EPCs with high doses of NMDAR channel
pore blockers induces apoptosis. Earlier on, we have shown
that high doses of memantine or MK-801 (above 100 or 50
M, respectively) resulted in cell death, which was particularly
pronounced for the early differentiation stages (18, 35). Herein
we have extended this observation by analyzing the mechanism
of cell death induced by high doses of pore-targeting NMDAR
blockers. Incubation of basophilic erythroblasts with 500 M
MK-801 or memantine (the dose toxic for both blockers) for 12
h in the SFEM culture medium induced activation of caspase 3,
caspase 8, and caspase 9 in the majority of cells (Fig. 8 and
Table 4). Phosphatidylserine exposure was enhanced in EPCs
exposed to both NMDAR antagonists (Fig. 8 and Table 5).
Hyperactivation of the receptors by additional supplementation
of NMDA (500 M) and glycine (100 M) to the culture
medium caused only modest adverse effects (Table 5).
DISCUSSION
Plasticity of NMDAR and whole cell currents during
erythropoiesis. The functional plasticity of the NMDAR during
EPC differentiation is the most striking finding of this study. A
dynamic switch in the subunit expression patterns was pre-
cisely mirrored by changes in the NMDAR channel function.
These events contributed to the general remodeling of the
membrane reflected by the changes in shape of the I–V curves
observed in the course of EPC differentiation.
During differentiation from basophilic to polychromatic
erythroblasts, the GluN2A subunit of the NMDAR in the cells
was substituted by the GluN2C subunit, whereas the expres-
sion and abundance of the other subunits, of which GluN2D
and 3B subunits were dominating, remained unchanged. The
electrophysiological properties of NMDAR in EPCs at any of
the stages tested exhibited high similarity to those in their
counterparts in neurons (49). Namely, proerythroblasts and
basophilic erythroblasts exhibited an NMDAR subtype with
high amplitude and fast deactivation kinetics reported for the
GluN2A-containing receptors (49). These receptors enable
efficient glutamate-induced changes in transmembrane poten-
tial and massive short-term Ca2 uptake. At these stages of
maturation, EPCs were reported to be particularly dependent
on Ca2-driven signaling. The latter is activated upon binding
of erythropoietin to its receptors (42, 43) and engaged in
control of a number of other processes of which iron process-
ing in erythroblasts is one of the most important (20). The peak
of Epo receptor expression is associated with the highest
NMDA-evoked Ca2 influx, fast deactivation time, and high
conductance (Fig. 3, A–C) (11, 15, 42). Our findings indicate
that prolonged exposure to high antagonist concentration en-
Fig. 3. Whole cell currents induced by EPC stimulation with NMDA and glycine. NMDA-induced currents were recorded in whole cell configuration at holding
potential 	60 mV. A: original recordings for the cells exposed to NMDA (150 M) and GLY (50 M) at day 8 (top, n  64 cells), day 12 (center, n  59
cells), day 16 (bottom, n  47 cells). B: alteration of current density of whole cell currents during erythropoietic maturation (***P 
 0.001 compared with day
8). C: alteration of deactivation time during maturation (***P 
 0.001 compared with day 8). D: deactivation of whole cell currents upon repetitive application
of NMDA and GLY in EPCs at day 12 in culture. E: no significant deviation in percentage of EPCs responding to NMDAR activation recorded using flow
cytometry and electrophysiology (P  0.05). EPCs from four different donors were analyzed for patch-clamp techniques (day 8, n  486 cells; day 12, n  458
cells; day 16, n  487 cells) and from nine different donors for flow cytometry. F: application of the 60 M MK-801 or 80 M memantine reduced the current
density significantly immediately after induction of NMDA currents (**P 
 0.01 and ***P 
 0.001). G: reduced current density after MK-801 (60 M)
application during repetitive voltage steps were applied. Black trace shows current density without antagonist application after NMDAR activation and gray trace
shows current density with MK-801 application after NMDAR activation. All data are means  SD and were recorded at 100 mV.
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hances phosphatidylserine exposure (Fig. 8). This supports the
hypothesis that the maintenance of NMDAR function is crucial
for protection against apoptosis in proerythroblasts and baso-
philic erythroblasts. These observations are in agreement with
the earlier studies in which requirement of the extracellular
Ca2 for survival and further differentiation of the EPC was
postulated (42). Detailed investigation of the molecular mech-
anisms of involvement of NMDAR in protection of the EPCs
from apoptosis was outside the scope of this study. In neural
progenitor cells, activation of NMDARs causes transient re-
cruitment of activator protein-1 (AP-1) to the DNA, followed
with suppression in proliferation and induction of differentia-
1 pA
1 pA
1 pA
1 pA
+40 mV
0 mV
-20 mV
-40 mV
***
1 s 1 s
2 pA 2 pA
Extracellular Solution NMDA/GLY
A
B
C
G = 23.1   2.4 pS+-
Fig. 4. Activation and deactivation of single channels after NMDAR activation. Single-channel recordings were performed in cell-attached configuration to
monitor spontaneous single-channel activity and its alteration in response to the stimulation with 150 M NMDA and 50 M glycine. A: mean single-channel
conductance (G) was 23.1  2.4 pS (n  4). V, voltage; I, current. B: single-channel recording before (left) and after (right) NMDA/GLY application. Holding
potential was fixed at 	40 mV. C: change in open probability and number of open channels (NPopen) upon NMDA/GLY application (n  96 cells). ECS,
extracellular solution. Data are means  SD (***P 
 0.001).
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tion (29). In erythroid cells, AP-1 is known to be involved in
regulation of proliferation and survival in Epo-dependent ery-
throid cells via controlling the activity of c-Jun and JunB
transcription factors (23, 33).
Our results suggest that NMDARs may contribute to Epo-
driven Ca2 signaling along with TRP channels described
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Fig. 5. Donor dependence of Ca2 influx, receptor properties, and GRIN2A
expression during hematopoiesis. mRNA expression was normalized to
GAPDH. A: correlation between GRIN2A mRNA expression and relative
change in geometric mean fluorescence (GMF) in the stimulated EPCs.
Correlation coefficient was calculated by the change in GMF triggered by the
agonists and the relative mRNA expression from six donors. B: correlation of
current density and relative GRIN2A mRNA expression (n 4). C: correlation
of deactivation time and relative GRIN2A mRNA expression from four donors.
Data are means  SD; linear (A and B) and exponential (C) functions were
used for curve fitting.
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Fig. 6. Stage dependence of Ca2 influx, receptor properties, and GRIN2C/3B
expression during hematopoiesis. mRNA expression was normalized to
GAPDH. A: correlation of relative GRIN2C and GRIN3B mRNA expression
(n  9) and relative change in GMF after NMDAR activation (n  9). B:
correlation of current density and relative GRIN2C/3B mRNA expression
during erythropoietic maturation (n  6). C: correlation of deactivation time
and relative GRIN2C/3B mRNA expression during erythropoietic maturation
(n  6). Data are means  SD (correlation coefficients see Table 4).
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earlier (15, 42, 44). Each of these channels mediating Ca2
uptake respond to its own set of stimuli supporting a complex
cross-talk between multiple receptors which drive the EPC
differentiation process. Further studies are required to charac-
terize the functional and possible physical interaction between
these two types of channels.
Maturation to polychromatic and orthochromatic erythroblasts
and finally to reticulocytes and RBCs is associated with a gradual
replacement of this NMDAR type with the one mediating slowly
decaying currents of smaller amplitude (Figs. 3 and 6, B and C).
Induction of expression of the GluN2C subunit, which replaces
GluN2A in receptors also containing the GluN2D and GluN3B
subunits, coincides with the onset of hemoglobinization [day 10 in
culture according to Wickrema et al. (60) and Fig. 1]. Regulation
of exocytosis of transferrin, its receptor recycling, and that of iron
uptake by the EPCs in mice, rats, and rabbits is controlled by
Ca2/calmodulin and is bound to sense the changes in Ca2
uptake mediated by the NMDARs (20). Apart from their possible
involvement in iron handling at the later stages of EPC differen-
tiation, “slow” NMDARs are best suited for the regulation of
basal Ca2 levels. Together with other Ca2-permeable ion chan-
nels, such as voltage-dependent anion channels and voltage-gated
calcium channel Cav2.1, which have been characterized in RBCs
(25), these channels contribute to the regulation of cell volume,
redox balance control, proteolysis, and O2 affinity for hemoglobin
(5, 18, 35).
Glutamate signaling in the microenvironment of EPCs.
Fluctuations of glutamate levels in peripheral blood are mir-
Current type A
Current type B
Current type C
40 mV
50 ms
A
B
C
D
200 pA
200 pA
50 ms
50 ms
100 pA
50 ms
Mean current density
E
Lowest current density
Current type B
Current type C
Fig. 7. Alteration in electrophysiological
properties during hematopoiesis. Cells were
voltage clamped in whole cell configuration
during hematopoiesis, and voltage steps
(10-mV increments) from 	120 mV to 60
mV were applied for 200 ms. Current was
normalized to cell capacitance (pA/pF) A:
frequently observed whole cell currents (type
A current, 86 cells) from early and interme-
diate stages of hematopoiesis (until day 15).
B: frequently observed whole cell currents
(type B current, 79 cells) from late stage of
erythropoietic maturation (from day 16 on).
C: infrequently observed type of whole cell
currents (type C current, 8 cells) from late
stage (day 18). D: voltage-step protocol and
three examples for the three whole cell cur-
rent types. E: analysis of voltage-current re-
lationship from four different donors at day
18 of differentiation. Data are means  SD
(n  76 cells).
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rored by alterations in the activity of erythroid NMDARs.
Recently, we have shown that NMDARs in RBCs show a high
degree of basal activity when in the circulation (18). Addition-
ally, glutamate levels within the bone marrow may be regu-
lated by controlled secretion of this amino acid from mega-
karyocytes and macrophages (3, 22, 32, 39). The close asso-
ciation of bone marrow and glutamatergic nerve endings may
further contribute to the alterations in glutamate levels promot-
ing erythropoiesis and increasing RBC production. However,
the exact range of glutamate levels therein has never been
measured. We have shown that hyperactivation of NMDARs in
young and mature RBCs, particularly those in sickle cell
disease patients, was associated with a transient increase in
Ca2, cell shrinkage, and oxidative burst (18). Prolonged
chronic activation of NMDARs in EPCs causes receptor de-
sensitization (Fig. 3D) but does not induce apoptosis in pre-
cursor cells (Fig. 8). We suggest that the desensitization is
essential for cytoprotection as it controls Ca2 uptake. Further-
more, Ca2 oscillations mediated during the activation-deacti-
vation cycles are used for signal transduction by a majority of
cells (2, 51). The regulatory mechanisms and the physiological
role of NMDARs expressed in EPCs as well as in other
hematopoietic progenitors giving rise to leucocytes, and plate-
lets require further investigation (28, 41). The pronounced
toxic effect of NMDAR inhibition may be attributed to the
importance of these receptors and Ca2 fluxes they mediate for
sustaining the EPCs’ survival (42), but it more likely represents
the off-target action of the receptor blockers at high concen-
trations (31).
In several studies, the receptors containing GluN2C/2D and
GluN3B subunits were shown to have lower sensitivity to the
channel pore blockers MK-801 and memantine and to Mg2
block (7, 38, 54). Thus, the reduced efficiency of the pore-
targeting MK-801 to inhibit NMDA currents is most likely
associated with the unusual subunit compositions of erythroid
NMDAR in which GluN1 is underrepresented, whereas
GluN3B and 2D were most abundant. The low conductance
and slow deactivation time we have observed for NMDARs in
polychromatic erythroblasts were shown to be characteristic
for the receptor formed by the GluN2C/D and GluN3B sub-
units (49). Currents mediated by the NMDAR in proerythro-
blasts showed no plateau phase as it was reported for the
NMDAR currents in neuronal cells (4). These findings indicate
that an atypical subunit composition and functional pattern of
NMDAR in erythroid cells resemble the properties of the
receptors described for other nonneuronal tissues (7, 28, 39).
Interindividual variability in quantity and quality of red
blood cell production. We have observed marked intercellular
and interindividual variability in the expression pattern and
abundance of NMDAR subunits in EPCs of healthy humans
(Fig. 5, B and C). However, repetitive measurements per-
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Fig. 8. Downstream activation of caspases and enhanced phosphatidylserine
(PS) exposure after long-term blockage of NMDAR in differentiating EPCs.
EPCs obtained from three donors and cultured for 12 days were incubated for
12 h at 37°C in the presence of 500 M MK-801 or memantine or were
supplemented with NMDA in addition to the medium-borne agonists (510 M
glutamate and 400 M glycine). Cells were stained with caspase activity
marker or FITC-labeled annexin-V antibody. Caspases 3, 8, and 9 were all
upregulated (gate A) after long-term incubation (shown in yellow) with
MK-801 and memantine (only MK-801 shown). High concentration of NMDA
did not affect caspase activity (data not shown). PS exposure was increased
(gate A) after long-term inhibition of NMDAR (only memantine shown).
Overactivation of NMDAR (NMDA/GLY) with 500 M NMDA and 100 M
glycine did not influence annexin-V binding (blue histogram) significantly.
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formed for NMDARs in EPCs derived from CD34 cells of
the same donor were highly reproducible. Interindividual vari-
ability of the GRIN gene transcript levels could represent
individual genetic, epigenetic, and signaling profiles (19). In-
tercellular heterogeneity in part reflects heterogeneity of the
EPC maturation stages in culture. However, this heterogeneity
in NMDAR abundance is persistent in circulating RBCs inde-
pendent of cell age, suggesting that, despite similar morphol-
ogy, several subpopulations of RBCs and EPCs are produced
representing “glutamate-sensitive” and “glutamate-resistant”
cells (18, 35). Expression patterns of GRIN2A and GRIN2C
define the properties of the NMDARs as the levels in GRIN2A
transcripts in the individual donors are proportional to the peak
amplitudes of glutamate-sensitive currents and Ca2 uptake,
and are inversely proportional to the deactivation time duration
(Figs. 5 and 6).
Based on the finding that enhanced Ca2 influx is a trigger
for increased terminal erythropoiesis (15, 42) we have sug-
gested that GluN2A-containing NMDAR contributes to this
essential Ca2 uptake. This would imply that the interindi-
vidual variability in number of receptors per cell and its subunit
composition might have an influence on red blood cell produc-
tion, properties, and clearance (5). These observations concur
with previous reports on the interindividual and inter-cellular
variability in sensitivity to NMDAR agonists such as glutamate
or homocysteine. The degree of glutamate-sensitivity of RBCs
of healthy human individuals may contribute to the quality of
stored blood products and the outcome of transfusion (35).
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